I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia
I3C 十年:儿童心血管暴露和阿尔茨海默氏痴呆的差异和公平
基本信息
- 批准号:10653088
- 负责人:
- 金额:$ 305.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskBiological MarkersBlack PopulationsBloodBlood PressureBlood VesselsCardiovascular systemChildChildhoodClinicalClinical Practice GuidelineCognitiveCohort StudiesCollaborationsDataData SetDevelopmentDisadvantagedDisparityEducationElderlyEquityEthnic PopulationEventExposure toFactor AnalysisGenerationsGeographyGlucoseGreen spaceGrowthHealthHeartImpaired cognitionIndividualIndole-3-CarbinolInternationalInvestmentsJointsKnowledgeLifeLife Cycle StagesLipidsLongitudinal StudiesMeasuresMetabolicNational Heart, Lung, and Blood InstituteNational Institute on AgingNon-Insulin-Dependent Diabetes MellitusObesityParticipantPopulationPostmenopausePremenopausePrevalencePreventionProcessRecording of previous eventsReproducibilityResearchRisk FactorsSamplingTimeUnited States National Institutes of HealthVascular SystemWeatherWomanWorkYouthblood-based biomarkerboysbrain healthcardiovascular healthcardiovascular risk factorclinical developmentcognitive performancecognitive testingcohortcritical perioddata harmonizationdata resourcedementia riskdisease disparityeffective therapyfollow-upfood securitygeographic disparitygirlshealth datahealth disparityin uteroindexingmenmiddle agenovelopen datapollutantpopulation basedprogression riskprospectivepublic health relevanceracial disparityracial populationresearch studysexsocioeconomic disadvantagesocioeconomics
项目摘要
SUMMARY
Risk for Alzheimer’s Disease and related dementias (ADRD) remains higher in black populations than in other
race/ethnic groups.This may be due at least in part to accumulated disadvantage which accelerates the
progression of cardiovascular (CV) risk factors, that in turn may contribute to the development of clinically
silent Alzheimer’s pathology as early as middle age. Our team has demonstrated that exposure to CV risk
factors such as obesity, elevated glucose, lipids and blood pressure can impact the vascular system by
childhood and even in utero. Early vascular changes, in turn, may contribute to changes in brain health
decades later. Despite documented socioeconomic and geographic disadvantages more often encountered by
blacks (in, e.g., food security, green spaces, education quality, pollutants) that promote CV health disparities
in childhood, there is little data examining such influences on Alzheimer’s related brain health in midlife or
later. This is primarily due to limited prospectively collected, life-course data on blacks. Addressing this
knowledge gap is increasingly urgent, as many more black and white children will develop adverse CV profiles
now as compared to previous generations. We propose to leverage the significant NIH investment in
prospectively collected data, from black and white men and women participating in the Bogalusa Heart Study
(BHS), NHLBI Growth and Health Study (NGHS), and Princeton Lipid Research Study (PLRS). These unique
life course studies have a strong history of collaboration and data harmonization formalized since 2009 through
the international childhood CV cohort consortium (I3C), with joint follow-up of CV events since 2015.
Shared exposure data include geographic, socioeconomic, and CV risk factors in childhood (from ages 3-19
years), with 40+ years of follow-up. Measuring brain health indicators in these cohorts will allow, for the first
time, exploration of the impact of early life CV health disparities and antecedent disadvantages on midlife brain
health in blacks and whites. In the proposed study, Disparities and Equity in Childhood CV Exposure and
Alzheimer’s DEmentia (I3C DECADE), we will collect structural, functional, cognitive and blood-based
indicators of ADRD-related brain health processes in mid-life (40-55 years), a period when the subtle impacts
of subclinical vascular changes on brain health first begin to emerge, often several decades before ADRD
become clinically evident. The PIs of these cohort studies will leverage their ongoing collaboration to build and
share a novel data resource that advances open science in early life risk factors, and extends that effort to
ADRD. The impact of this work will be to inform strategies that may reduce ADRD health disparities by
identifying and intervening among black and white boys and girls whose CV burden places them at increased
risk of ADRD decades later and has the potential to lead to changes in pediatric clinical practice guidelines.
The proposed I3C DECADE Study represents a unique, and arguably the only opportunity to investigate the
influence of childhood CV risk and disparities on ADRD-related brain health in the critical period of midlife.
概括
黑人患阿尔茨海默病和相关痴呆症 (ADRD) 的风险仍然高于其他人群
种族/族裔群体。这可能至少部分是由于累积的劣势加速了
心血管(CV)危险因素的进展,反过来可能有助于临床疾病的发展
我们的团队已经证明,接触心血管疾病的风险早在中年就已出现。
肥胖、血糖升高、血脂和血压等因素会通过以下方式影响血管系统:
童年甚至子宫内的早期血管变化反过来可能会导致大脑健康的变化。
几十年后,尽管有记录的社会经济和地理劣势更经常遇到。
黑人(在食品安全、绿地、教育质量、污染物等方面)加剧了CV健康差异
在童年时期,几乎没有数据检验这种对中年或中年阿尔茨海默氏症相关大脑健康的影响。
这主要是由于针对黑人的前瞻性收集的生命历程数据有限。
知识差距日益紧迫,因为更多的黑人和白人儿童将发展出不良的简历
与前几代相比,我们现在建议利用 NIH 的大量投资。
前瞻性收集的数据来自参与 Bogalusa 心脏研究的黑人和白人男性和女性
(BHS)、NHLBI 生长与健康研究 (NGHS) 和普林斯顿脂质研究 (PLRS) 这些都是独一无二的。
生命历程研究有着悠久的合作和数据协调历史,自 2009 年以来通过
国际儿童 CV 队列联盟 (I3C),自 2015 年以来对 CV 事件进行联合随访。
共享暴露数据包括儿童时期(3-19 岁)的地理、社会经济和心血管风险因素
年),通过对这些人群进行 40 多年的随访,测量大脑健康指标将首次实现这一目标。
时间,探索早年CV健康差异和先行劣势对中年大脑的影响
在拟议的研究中,黑人和白人的健康状况存在差异。
阿尔茨海默氏痴呆(I3C DECADE),我们将收集结构、功能、认知和血液方面的信息
中年(40-55岁)ADRD相关大脑健康过程的指标,这是一个微妙影响的时期
亚临床血管变化对大脑健康的影响首先开始出现,通常早于 ADRD 几十年
这些队列研究的 PI 将利用他们正在进行的合作来建立和实现。
分享新颖的数据资源,推动早期生命风险因素的开放科学,并将这一努力扩展到
这项工作的影响将是通过以下方式提供可能减少 ADRD 健康差异的策略:
识别和干预那些简历负担增加的黑人和白人男孩和女孩
几十年后 ADRD 的风险,并有可能导致儿科临床实践指南的变化。
拟议的 I3C DECADE 研究代表了一个独特的、可以说是唯一的研究机会
儿童心血管风险和中年关键时期 ADRD 相关大脑健康差异的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lydia Bazzano其他文献
Lydia Bazzano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lydia Bazzano', 18)}}的其他基金
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia
I3C 十年:儿童心血管暴露和阿尔茨海默氏痴呆的差异和公平
- 批准号:
10449003 - 财政年份:2022
- 资助金额:
$ 305.12万 - 项目类别:
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health
生命早期心血管疾病危险因素、表观遗传年龄加速和阿尔茨海默病相关的大脑健康
- 批准号:
10706044 - 财政年份:2022
- 资助金额:
$ 305.12万 - 项目类别:
Tulane University Training Program for Diversity in tRanslation and Implementation research in cardioVascular disEase (DRIVE)
杜兰大学心血管疾病翻译和实施研究多样性培训计划 (DRIVE)
- 批准号:
10646467 - 财政年份:2021
- 资助金额:
$ 305.12万 - 项目类别:
Tulane University Training Program for Diversity in tRanslation and Implementation research in cardioVascular disEase (DRIVE)
杜兰大学心血管疾病翻译和实施研究多样性培训计划 (DRIVE)
- 批准号:
10255155 - 财政年份:2021
- 资助金额:
$ 305.12万 - 项目类别:
Tulane University Training Program for Diversity in tRanslation and Implementation research in cardioVascular disEase (DRIVE)
杜兰大学心血管疾病翻译和实施研究多样性培训计划 (DRIVE)
- 批准号:
10432093 - 财政年份:2021
- 资助金额:
$ 305.12万 - 项目类别:
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
早期血糖状况和中年阿尔茨海默病神经影像学标志物:Bogalusa 心脏研究
- 批准号:
10535457 - 财政年份:2019
- 资助金额:
$ 305.12万 - 项目类别:
Supplemental Funding Request for RF1 AG062309 Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
RF1 AG062309 的补充资金申请 早期血糖状态和中年阿尔茨海默病神经影像标记:Bogalusa 心脏研究
- 批准号:
10161514 - 财政年份:2019
- 资助金额:
$ 305.12万 - 项目类别:
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
早期血糖状况和中年阿尔茨海默病神经影像学标志物:Bogalusa 心脏研究
- 批准号:
10318574 - 财政年份:2019
- 资助金额:
$ 305.12万 - 项目类别:
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
早期血糖状况和中年阿尔茨海默病神经影像学标志物:Bogalusa 心脏研究
- 批准号:
10064986 - 财政年份:2019
- 资助金额:
$ 305.12万 - 项目类别:
A novel research infrastructure enabling life-course studies of healthy aging
新型研究基础设施可实现健康老龄化的生命历程研究
- 批准号:
10475012 - 财政年份:2018
- 资助金额:
$ 305.12万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 305.12万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 305.12万 - 项目类别:
Examining the Effectiveness of the Early Start Denver Model in Community Programs serving Young Autistic Children
检查早期开始丹佛模式在为自闭症儿童服务的社区项目中的有效性
- 批准号:
10725999 - 财政年份:2023
- 资助金额:
$ 305.12万 - 项目类别:
Development of M-Drive: A recyclable Mucor-optimized CAS9 gene-drive system cable of multi-target gene editing
开发M-Drive:可回收的多靶点基因编辑的毛霉优化CAS9基因驱动系统电缆
- 批准号:
10727359 - 财政年份:2023
- 资助金额:
$ 305.12万 - 项目类别:
Plasma neurofilament light chain as a potential disease monitoring biomarker in Wolfram syndrome
血浆神经丝轻链作为 Wolfram 综合征潜在疾病监测生物标志物
- 批准号:
10727328 - 财政年份:2023
- 资助金额:
$ 305.12万 - 项目类别: